Literature DB >> 34886685

Development and Validation of a Long-Term Incident Heart Failure Risk Model.

Sadiya S Khan1,2, Hongyan Ning2, Norrina B Allen2, Mercedes R Carnethon2, Clyde W Yancy1, Sanjiv J Shah1, John T Wilkins1,2, Lu Tian2, Donald M Lloyd-Jones1,2.   

Abstract

BACKGROUND: Average lifetime risk for heart failure (HF) is high but differs significantly across and within sex-race groups. No models for estimating long-term risk for HF exist, which would allow for earlier identification and interventions in high-risk subsets. The authors aim to derive 30-year HF risk equations.
METHODS: Adults between the ages of 20 to 59 years and free of cardiovascular disease at baseline from 5 population-based cohorts were included. Among 24 838 participants (55% women, 25% Black based on self-report), follow-up consisted of 599 551 person-years. Sex- and race-specific 30-year HF risk equations were derived and validated accounting for competing risk of non-HF death. HF was based on a clinical diagnosis. Model discrimination and calibration were assessed using 10-fold cross-validation. Finally, the model was applied to varying risk factor patterns for systematic examination.
RESULTS: The rate of incident HF was 4.0 per 1000 person-years. Harrell C statistics were 0.82 (0.80-0.83) and 0.84 (0.82-0.85) in White and Black men and 0.84 (0.82-0.85) and 0.85 (0.83-0.87) in White and Black women, respectively. Hosmer-Lemeshow calibration was acceptable, with χ2 <30 in all subgroups. Risk estimation varied across sex-race groups: for example, in an average 40-year-old nonsmoker with an untreated systolic blood pressure of 140 mm Hg and body mass index of 30 kg/m2, risk was estimated to be 22.8% in a Black man, 13.7% in a White man, 13.0% in a Black woman, and 12.1% in a White woman.
CONCLUSIONS: Sex- and race-specific equations for prediction of long-term risk of HF demonstrated high discrimination and adequate calibration.

Entities:  

Keywords:  adult; female; humans; male; young adult

Mesh:

Year:  2021        PMID: 34886685      PMCID: PMC8776614          DOI: 10.1161/CIRCRESAHA.121.319595

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  40 in total

1.  An approach to longitudinal studies in a community: the Framingham Study.

Authors:  T R DAWBER; W B KANNEL; L P LYELL
Journal:  Ann N Y Acad Sci       Date:  1963-05-22       Impact factor: 5.691

2.  Lifetime risks of cardiovascular disease.

Authors:  Jarett D Berry; Alan Dyer; Xuan Cai; Daniel B Garside; Hongyan Ning; Avis Thomas; Philip Greenland; Linda Van Horn; Russell P Tracy; Donald M Lloyd-Jones
Journal:  N Engl J Med       Date:  2012-01-26       Impact factor: 91.245

3.  Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.

Authors:  Bernard Zinman; Christoph Wanner; John M Lachin; David Fitchett; Erich Bluhmki; Stefan Hantel; Michaela Mattheus; Theresa Devins; Odd Erik Johansen; Hans J Woerle; Uli C Broedl; Silvio E Inzucchi
Journal:  N Engl J Med       Date:  2015-09-17       Impact factor: 91.245

4.  Sex and Race Differences in Lifetime Risk of Heart Failure With Preserved Ejection Fraction and Heart Failure With Reduced Ejection Fraction.

Authors:  Ambarish Pandey; Wally Omar; Colby Ayers; Michael LaMonte; Liviu Klein; Norrina B Allen; Lewis H Kuller; Philip Greenland; Charles B Eaton; John S Gottdiener; Donald M Lloyd-Jones; Jarett D Berry
Journal:  Circulation       Date:  2018-01-19       Impact factor: 29.690

5.  An investigation of coronary heart disease in families. The Framingham offspring study.

Authors:  W B Kannel; M Feinleib; P M McNamara; R J Garrison; W P Castelli
Journal:  Am J Epidemiol       Date:  1979-09       Impact factor: 4.897

6.  The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators.

Authors: 
Journal:  Am J Epidemiol       Date:  1989-04       Impact factor: 4.897

7.  A systematic examination of the 2013 ACC/AHA pooled cohort risk assessment tool for atherosclerotic cardiovascular disease.

Authors:  Kunal N Karmali; David C Goff; Hongyan Ning; Donald M Lloyd-Jones
Journal:  J Am Coll Cardiol       Date:  2014-09-09       Impact factor: 24.094

8.  2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.

Authors:  Piotr Ponikowski; Adriaan A Voors; Stefan D Anker; Héctor Bueno; John G F Cleland; Andrew J S Coats; Volkmar Falk; José Ramón González-Juanatey; Veli-Pekka Harjola; Ewa A Jankowska; Mariell Jessup; Cecilia Linde; Petros Nihoyannopoulos; John T Parissis; Burkert Pieske; Jillian P Riley; Giuseppe M C Rosano; Luis M Ruilope; Frank Ruschitzka; Frans H Rutten; Peter van der Meer
Journal:  Eur Heart J       Date:  2016-05-20       Impact factor: 29.983

9.  Primary prevention of heart failure.

Authors:  Javed Butler
Journal:  ISRN Cardiol       Date:  2012-08-16

10.  Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Authors:  Melanie J Davies; David A D'Alessio; Judith Fradkin; Walter N Kernan; Chantal Mathieu; Geltrude Mingrone; Peter Rossing; Apostolos Tsapas; Deborah J Wexler; John B Buse
Journal:  Diabetes Care       Date:  2018-10-04       Impact factor: 19.112

View more
  3 in total

Review 1.  New strategies and therapies for the prevention of heart failure in high-risk patients.

Authors:  Michael M Hammond; Ian K Everitt; Sadiya S Khan
Journal:  Clin Cardiol       Date:  2022-06       Impact factor: 3.287

2.  Distribution of 10- and 30-Year Predicted Risks for Heart Failure in the US Population: National Health and Nutrition Examination Surveys 2015 to 2018.

Authors:  Zachary H Hughes; Hongyan Ning; Sanjiv J Shah; Clyde W Yancy; John T Wilkins; Donald M Lloyd-Jones; Sadiya S Khan; Nilay S Shah
Journal:  Circ Heart Fail       Date:  2022-04-04       Impact factor: 10.447

3.  Long-Term Risk Prediction for Heart Failure, Disparities, and Early Prevention.

Authors:  Steven Shea; Michael J Blaha
Journal:  Circ Res       Date:  2022-01-20       Impact factor: 23.213

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.